Gemcitabine and vascular toxicity.
作者信息
Muñoz A, Mañé J M, Rubio I, Fernández R, Fuente N, Barceló R, López Vivanco G
出版信息
Lung Cancer. 2002 Aug;37(2):229. doi: 10.1016/s0169-5002(02)00152-6.
Abstract
摘要
相似文献
1
Gemcitabine and vascular toxicity.
Lung Cancer. 2002 Aug;37(2):229. doi: 10.1016/s0169-5002(02)00152-6.
2
Vasculitis due to gemcitabine.
Lung Cancer. 2002 May;36(2):203-5. doi: 10.1016/s0169-5002(01)00464-0.
3
Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
Arch Ophthalmol. 2000 May;118(5):726-7. doi: 10.1001/archopht.118.5.726.
4
Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
Lung Cancer. 2001 Jan;31(1):83-5. doi: 10.1016/s0169-5002(00)00159-8.
5
Veno-occlusive disease of the liver induced by gemcitabine.
Ann Oncol. 1998 Jun;9(6):681. doi: 10.1023/a:1008225930573.
6
Gemcitabine for lung cancer.
Drug Ther Bull. 1996 Sep;34(9):71-2.
7
Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
Chest. 1998 Dec;114(6):1779-81. doi: 10.1378/chest.114.6.1779.
8
Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
Anticancer Drugs. 1995 Dec;6 Suppl 6:5-65.
9
Severe neurotoxicity caused by gemcitabine treatment.
Acta Oncol. 2004;43(6):590-1. doi: 10.1080/02841860410018494.
10
[Interstitial lung disease in a patient given gemcitabine].
Rev Pneumol Clin. 2002 Feb;58(1):23-6.
Zotero 插件